M Schuiveling, N Vazirpanah… - Current drug …, 2018 - ingentaconnect.com
Background: Metformin, a widely prescribed blood glucose normalizing antidiabetic drug, is now beginning to receive increasing attention due to its anti-inflammatory properties …
R Kristófi, JW Eriksson - Journal of Endocrinology, 2021 - joe.bioscientifica.com
Metformin is a biguanide drug widely used as the initial treatment of type 2 diabetes. Despite its widespread use, its precise mechanisms of action remain incompletely characterised. Its …
Metformin is an oral hypoglycemic agent which is most widely used as first-line therapy for type 2 diabetes. Metformin improves hyperglycemia by suppressing hepatic glucose …
B Bai, H Chen - Frontiers in pharmacology, 2021 - frontiersin.org
It has become widely accepted that inflammation is a driving force behind a variety of chronic diseases, such as cardiovascular disease, diabetes, kidney disease, cancer …
Type 2 diabetes mellitus (T2DM) is the most common chronic metabolic condition. Several genetic and environmental factors are involved in developing T2DM. Aging, inflammation …
Y Hattori, K Hattori, T Hayashi - Diabetes, 2015 - Am Diabetes Assoc
Metformin is a biguanide family member used in the treatment of type 2 diabetes and one of the most widely prescribed antidiabetes drugs. This drug increases the peripheral uptake of …
KY Hur, MS Lee - Journal of diabetes investigation, 2015 - Wiley Online Library
The most well‐known mechanism of metformin action, one of the most commonly prescribed antidiabetic drugs, is adenosine monophosphate‐activated protein kinase activation; …
YY Feng, Z Wang, H Pang - Molecular biology reports, 2023 - Springer
Background Metformin has good anti-hyperglycemic effectiveness, but does not induce hypoglycemia, is very safe, and has become the preferred drug for the treatment of type 2 …
Metformin (dimethyl biguanide) is a synthetic derivative of guanidine, isolated from the extracts of Galega officinalis, a plant with a prominent antidiabetic effect. Since its discovery …